Formulation and in-vitro evaluation of floating capsules of Loratadine
The present work focuses on the
development of hydrodynamically balanced delivery system of loratadine as a
single unit floating capsules. Sustained release floating capsules for
loratadine were fabricated using drug:polymer ratio of 1:4. The hydrocolloids
were used in different proportions using 32 full factorial design and
formulations were prepared. These formulations were optimized on the basis of
buoyancy, matrix integrity, duration of floating and in vitro drug release. All
the nine formulations showed good buoyancy and matrix integrity. The duration
of floating was more than 12 h for all formulations. In vitro drug release study
of these formulations indicated controlled release of loratadine and about 90
percent drug was released at the end of 12 h.
Comments
Post a Comment